Survival benefit of adjuvant therapy following neoadjuvant therapy in patients with resected esophageal cancer: a retrospective cohort study

Weiyi Jia, Chao Li, Can Liu, Renwang Hu
doi: https://doi.org/10.1101/2024.05.23.24307798

Article Information

doi 
https://doi.org/10.1101/2024.05.23.24307798
History 
  • May 23, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Weiyi Jia2,
  2. Chao Li2,
  3. Can Liu3 and
  4. Renwang Hu1,*
  1. 1Department of Gastrointestinal Surgery, Henan Provincial People’s Hospital, Zhengzhou, Henan, China
  2. 2Department of Science & Education, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou 450007, PR China
  3. 3Department of Radiology, Henan Provincial People’s Hospital, Zhengzhou, Henan, China
  1. ↵*Correspondence: Renwang Hu, MD. Address:
    7 Weiwu Road. Zhengzhou, Henan 450000, China. E-mail:
    huhu1366{at}sina.com
Back to top
Posted May 23, 2024.
Download PDF
Data/Code
Email
Survival benefit of adjuvant therapy following neoadjuvant therapy in patients with resected esophageal cancer: a retrospective cohort study
Weiyi Jia, Chao Li, Can Liu, Renwang Hu
medRxiv 2024.05.23.24307798; doi: https://doi.org/10.1101/2024.05.23.24307798
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area